ASPs For Bundled Drugs Might Be Improved With “Exceptions” Process – MedPAC

CMS should consider creating a process to allow revisions of Part B average sales prices for drugs sold through bundled arrangements, to enhance the accuracy of ASPs, the Medicare Payment Advisory Commission suggests in comments to CMS